Alemtuzumab
Drug · tier A · 8 trials (0 recruiting) · 20 publications · score 73.0
Dexamethasone
Drug · tier A · 6 trials (1 recruiting) · 11 publications · score 68.0
Anti-Thymocyte Globulin
Drug · tier A · 8 trials (2 recruiting) · 4 publications · score 52.0
Sirolimus
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 47.0
Amphetamine
Drug · tier A · 2 trials (0 recruiting) · 7 publications · score 45.5
Abatacept
Drug · tier A · 3 trials (1 recruiting) · 4 publications · score 40.0
Indomethacin
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0
Indapamide
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 22.0
Acetazolamide
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 21.5
Methoxsalen
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 20.5
Research map, not treatment advice. Built 2026-10-07.